Till startsida
To content Read more about how we use cookies on gu.se

Ulrika Stierner


Ulrika Stierner
+46 31-342 1000

Postal Address: Su sahlgrenska, 41345 Göteborg
Visiting Address: Jubileumsklin, Blå str 2a SU , Göteborg

Department of Oncology at Institute of Clinical Sciences (More Information)
Sahlgrenska Universitetssjukhuset
413 45 Göteborg
Visiting Address: Blå stråket 2 SU/Jubileusklin , 413 45 Göteborg

Latest publications

Real-world data on PD-1 inhibitor therapy in metastatic melanoma
A. Arheden, J. Skalenius, Sara Bjursten, Ulrika Stierner, Lars Ny et al.
Acta Oncologica, Journal article 2019
Journal article

Accelerated or conventional whole brain irradiation of malignant melanoma.
Ragnar Hultborn, Johanna Sand, Sara Kinhult, Lotta Lundgren, Ulrika Stierner et al.
Acta oncologica (Stockholm, Sweden), Journal article 2017
Journal article

Melanomincidensen fortsätter att stiga.
Hildur Helgadottir, Ulrika Stierner
Lakartidningen, Magazine article 2017
Magazine article

An approach to suppress the evolution of resistance in BRAF(V600E)-mutant cancer
Y. H. Xue, L. Martelotto, T. Baslan, A. Vides, M. Solomon et al.
Nat Med, Journal article 2017
Journal article

Glycosaminoglycan Profiling in Patients' Plasma and Urine Predicts the Occurrence of Metastatic Clear Cell Renal Cell Carcinoma
Francesco Gatto, N. Volpi, H. Nilsson, Intawat Nookaew, M. Maruzzo et al.
Cell Reports, Journal article 2016
Journal article

Showing 31 - 40 of 60


Two different durations of adjuvant therapy with intermediate-dose interferon alfa-2b in patients with high-risk melanoma (Nordic IFN trial): a randomised phase 3 trial.
Johan Hansson, Steinar Aamdal, Lars Bastholt, Yvonne Brandberg, Micaela Hernberg et al.
The lancet oncology, Journal article 2011
Journal article


Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study.
T Tandstad, G Cohn-Cedermark, O Dahl, Ulrika Stierner, E Cavallin-Stahl et al.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, Journal article 2010
Journal article


Autoimmune antibodies and recurrence-free interval in melanoma patients treated with adjuvant interferon.
Marna G Bouwhuis, Stefan Suciu, Sandra Collette, Steinar Aamdal, Wim H Kruit et al.
Journal of the National Cancer Institute, Journal article 2009
Journal article

Risk-adapted treatment in clinical stage I nonseminomatous germ cell testicular cancer: the SWENOTECA management program.
Torgrim Tandstad, Olav Dahl, Gabriella Cohn-Cedermark, Eva Cavallin-Stahl, Ulrika Stierner et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Journal article 2009
Journal article



The prognostic role of blood lymphocyte subset distribution in patients with resected high-risk primary or regionally metastatic melanoma.
Micaela Hernberg, Petri S Mattila, Marjo Rissanen, Johan Hansson, Steinar Aamdal et al.
Journal of immunotherapy (Hagerstown, Md. : 1997), Journal article 2007
Journal article


Invasive cutaneous malignant melanoma in Sweden, 1990-1999. A prospective, population-based study of survival and prognostic factors.
Christer Lindholm, Ronny Andersson, Monika Dufmats, Johan Hansson, Christian Ingvar et al.
Cancer, Journal article 2004
Journal article


Showing 31 - 40 of 60

Page Manager: Katarina Olinder Eriksson|Last update: 3/28/2013

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?